Taken together, these results suggest the potential contribution of dermal fibroblasts of early SSc patients to recruiting Th17 cells to the affected skin lesion, as previously reported [13], and the activation of CCL20/CCR6 axis in endothelial cells and keratinocytes of SSc-involved skin. This evidence concerns the gene CCL20 and systemic sclerosis.